00680K:KRXMIRAE ASSET SECURITIES CO. LTD. Cum Pfd Registered Shs Analysis
Data as of 2026-03-15 - not real-time
₩22,000.00
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Mirae Asset Securities is trading at ₩22,000, comfortably above its 20‑day (≈₩20,567) and 50‑day (≈₩16,274) SMAs, indicating a short‑term bullish bias. Momentum remains moderate with an RSI of 60.9 and a bearish MACD histogram, while volume is tapering and 30‑day volatility is elevated at ~109%, suggesting price swings may intensify.
Fundamentally, the firm posts strong top‑line growth (13.8% YoY revenue expansion) and impressive margins (gross 95.8%, operating 30.6%, profit 7.0%). However, the balance sheet is strained: a debt‑to‑equity ratio of ~748 and negative operating cash flow raise solvency concerns, despite a modest dividend yield of 1.37% and a low payout ratio (≈11%). Recent corporate actions—treasury‑stock buyback, option grants, and technology funding—provide a positive catalyst, but analysts’ revised price target of ₩14,366 signals skepticism about near‑term upside.
Fundamentally, the firm posts strong top‑line growth (13.8% YoY revenue expansion) and impressive margins (gross 95.8%, operating 30.6%, profit 7.0%). However, the balance sheet is strained: a debt‑to‑equity ratio of ~748 and negative operating cash flow raise solvency concerns, despite a modest dividend yield of 1.37% and a low payout ratio (≈11%). Recent corporate actions—treasury‑stock buyback, option grants, and technology funding—provide a positive catalyst, but analysts’ revised price target of ₩14,366 signals skepticism about near‑term upside.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price above key moving averages
- Bearish MACD divergence
- High short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Robust revenue growth and margin profile
- Attractive price‑to‑sales multiple (~1.9x)
- Dividend yield with low payout ratio
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Elevated debt‑to‑equity and negative operating cash flow
- Regulatory exposure in capital‑markets sector
- Potential upside from ongoing buyback and tech investment
Key Metrics & Analysis
Financial Health
Revenue Growth1381.70%
Profit Margin7.05%
ROE10.47%
ROA0.91%
Debt/Equity747.67
Op. Cash Flow₩-8557951975424
Industry P/E16.4
Technical Analysis
TrendBullish
RSI60.9
Support₩0.00
Resistance₩24,173.04
MA 20₩20,566.99
MA 50₩16,274.28
MA 200₩10,714.44
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88
Valuation
GradeUndervalued
TypeBlend
Dividend Yield1.37%
Risk Assessment
Beta0.48
Volatility109.39%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.